|drug999||Data collection and rhinopharyngeal swab Wiki||1.00|
|D003324||Coronary Artery Disease NIH||0.38|
|D060825||Cognitive Dysfunction NIH||0.29|
There is one clinical trial.
The aim of this project is to study the safety and efficacy of anthocyanins in improving key dementia-related mechanisms and cognitive functioning in older people at risk for dementia. Secondary analyses will include a variety of biological measures, including biochemistry, imaging and cardiovascular measures.
Description: A composite measure from the CogTrack batteryMeasure: Quality of episodic memory. Time: Baseline to 24 weeks
Description: CogTrack evaluates attentional intensity index, sustained intensity index, cognitive reaction time, attentional fluctuation index, quality of working memory, quality of episodic memory and speed of memory retrieval.Measure: Secondary endpoints from CogTrack Time: Baseline to 24 weeks
Description: Lipid profile, fatty acids, cytokines ( among others: IL-1, IL-2, IL-6, TNF-a), plasma antoxidant status and vitamins (lipid peroxidation markers, vitamins E, C, A, total plasma antioxidant capacity, glutathion)., carinthine, blood glucose, HbA1c, anthocyanins and metabolites, mapping of a-beta degradation products.Measure: Blood outcome analysis Time: Baseline to 24 weeks
Description: Flow-mediated dilation (FMD), Cardiac-ankle vascular index (CAVI), photoplethysmogram (PPG).Measure: Cardiovascular parameters Time: Baseline to 24 weeks
Description: MicrobiotaMeasure: Fecal analysis Time: Baseline to 24 weeks
Description: kyrininMeasure: Urine analysis Time: Baseline to 24 weeks
Description: anthocyanin metabolitesMeasure: CSF measurements Time: Baseline to 24 weeks
Description: Diagnosing and follow-up of cerebrovascular diseaseMeasure: MR-imaging/CT Time: Baseline to 24 weeks
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports